US Stock MarketDetailed Quotes

AGIO Agios Pharmaceuticals

Watchlist
  • 32.130
  • +0.140+0.44%
Close Mar 11 16:00 ET
  • 32.130
  • 0.0000.00%
Post 16:05 ET
1.84BMarket Cap2.76P/E (TTM)

Agios Pharmaceuticals Key Stats

Agios Pharmaceuticals Q4 2024 Earnings Date

Currency:USDFeb 13, 2025

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
9.35M
10.73M
+1.38M
Beat Est.
+31.60%
+51.06%
+14.79%
EPS
-1.69
-1.74
-0.05
Miss Est.
+1.72%
-1.16%
-2.93%
Buy

Mar 3, 2025

Agios Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 10.424M--
--2025/Q1-- / 9.857M--
Feb 13, 20252024/Q410.730M / 9.347M--
Oct 31, 20242024/Q38.964M / 9.502M--
Aug 1, 20242024/Q28.615M / 9.307M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 10.424M--
--2025/Q1-- / 9.857M--
Feb 13, 20252024/Q410.730M / 9.347M--
Oct 31, 20242024/Q38.964M / 9.502M--
Aug 1, 20242024/Q28.615M / 9.307M--

Unlock Free Earnings Estimates

Agios Pharmaceuticals Earnings Reports

Read more

Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Mar 3, 2025

Buy

  • Buy

    71.43%
  • Hold

    28.57%
  • Sell

    0.00%

Price Target

No Data